By P Reed Maurer
Walk into any pharma company office in Japan and you will most likely see a plaque on a wall outlining the company’s mission. One of the statements will say: “Everything we do is to benefit patients,” notes long-time Japan pharma watcher and president of International Alliances Limited P Reed Maurer in his exclusive column for The Pharma Letter.
Is this an example of good public relations? A way to motivate employees? An effective strategy to yield positive business results? Or is it a mere slogan that has little or no effect on employees or business results?
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze